UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Annals of oncology, 2016-10, Vol.27 (10), p.1855-1860

2016

Link zum Volltext

Verfügbarkeit prüfen

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

Annals of oncology, 2014-09, Vol.25 (9), p.1762-1769

2014

Link zum Volltext

Verfügbarkeit prüfen

An analysis of efficacy and safety of olaratumab + doxorubicin or doxorubicin alone in patients with uterine leiomyosarcoma: A retrospective assessment of the phase 1b/2 study JGDG

Gynecologic oncology, 2017-06, Vol.145, p.93-93

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center

Gynecologic oncology, 2016-02, Vol.140 (2), p.307-312

2016

Link zum Volltext

Verfügbarkeit prüfen

1321 Efficacy and safety of trabectedin (T) or dacarbazine (D) in an elderly patient subgroup (65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy

European journal of cancer (1990), 2015-09, Vol.51, p.S194-S194

2015

Link zum Volltext

Verfügbarkeit prüfen

Gyn/onc partnership with sarcoma center yields superior clinical trial enrollments for uterine leiomyosarcoma patients

Gynecologic oncology, 2015-04, Vol.137, p.100-100

2015

Link zum Volltext

Verfügbarkeit prüfen

1934P Pharmacokinetics of unesbulin in a phase Ib study of patients with advanced leiomyosarcoma

Annals of oncology, 2023-10, Vol.34, p.S1039-S1039

2023

Link zum Volltext

Verfügbarkeit prüfen

1929P phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors

Annals of oncology, 2023-10, Vol.34, p.S1037-S1037

2023

Link zum Volltext

Verfügbarkeit prüfen

97P Bcl-xL prevents the arginine starvation induced by PEGylated arginine deiminase (ADI-PEG20) from inducing apoptosis

ESMO open, 2023-03, Vol.8 (1), p.100955, Article 100955

2023

Link zum Volltext

Verfügbarkeit prüfen

LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)

Annals of oncology, 2022-09, Vol.33, p.S1435-S1436

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Annals of oncology, 2018-09, Vol.29 (9), p.1995-2002

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiosarcoma: History of Prior Radiation Therapy is an Adverse Prognostic Factor

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e219-e219

2018

Link zum Volltext

Verfügbarkeit prüfen

1488MO Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT)

Annals of oncology, 2022-09, Vol.33, p.S1227-S1228

2022

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii592-viii592

2018

Link zum Volltext

Verfügbarkeit prüfen

735MO Updated safety and efficacy from SURPASS, the phase I trial of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in previously treated patients with unresectable or metastatic tumors

Annals of oncology, 2022-09, Vol.33, p.S879-S880

2022

Link zum Volltext

Verfügbarkeit prüfen

1677PD - A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v688-v688

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v688

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Annals of oncology, 2017-01, Vol.28 (1), p.121-127

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

Annals of oncology, 2018-10, Vol.29, p.viii579-viii579

2018

Link zum Volltext

Verfügbarkeit prüfen

1670O - ADP-A2M4 (MAGE-A4) in patients with synovial sarcoma

Annals of oncology, 2019-10, Vol.30, p.v684-v685

2019

Link zum Volltext

Verfügbarkeit prüfen

1687P - Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma

Annals of oncology, 2019-10, Vol.30, p.v692-v692

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma

Annals of oncology, 2019-10, Vol.30, p.v692

2019

Link zum Volltext

Verfügbarkeit prüfen

ADP-A2M4 (MAGE-A4) in patients with synovial sarcoma

Annals of oncology, 2019-10, Vol.30, p.v684-v685

2019

Link zum Volltext

Verfügbarkeit prüfen

Multi-institutional Analysis of Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases: High Rates of Local Control with Favorable Toxicity

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S77-S78

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Annals of oncology, 2018-10, Vol.29, p.viii670-viii670

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(6)
Adult
(5)
Aged
(5)
Aged, 80 And Over
(5)
Female
(5)
Life Sciences & Biomedicine
(5)
Middle Aged
(5)
Science & Technology
(5)
Hematology, Oncology And Palliative Medicine
(4)
Male
(4)
Oncology
(4)
Original
(4)
Disease-Free Survival
(3)
Leiomyosarcoma - Drug Therapy
(3)
Leiomyosarcoma - Pathology
(3)
Obstetrics And Gynecology
(3)
Antineoplastic Agents - Therapeutic Use
(2)
Hematology
(2)
Kaplan-Meier Estimate
(2)
Liposarcoma - Drug Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(25)
RCN full-text journals@Ovid
(21)
Ingenta
(8)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(6)
MEDLINE
(6)
Elsevier ScienceDirect Journals
(6)
IngentaConnect Journals
(5)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(21)
Esmo Open
(4)
Gynecologic Oncology
(3)
International Journal Of Radiation Oncology, Biology, Physics
(2)
Cytogenetic And Genome Research
(1)
European Journal Of Cancer
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

An analysis of efficacy and safety of olaratumab + doxorubicin or doxorubicin alone in patients with uterine leiomyosarcoma: A retrospective assessment of the phase 1b/2 study JGDG

Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center

1321 Efficacy and safety of trabectedin (T) or dacarbazine (D) in an elderly patient subgroup (65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy

Gyn/onc partnership with sarcoma center yields superior clinical trial enrollments for uterine leiomyosarcoma patients

1934P Pharmacokinetics of unesbulin in a phase Ib study of patients with advanced leiomyosarcoma

1929P phase II results from the RINGSIDE phase II/III trial of AL102 for treatment of desmoid tumors

97P Bcl-xL prevents the arginine starvation induced by PEGylated arginine deiminase (ADI-PEG20) from inducing apoptosis

LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Angiosarcoma: History of Prior Radiation Therapy is an Adverse Prognostic Factor

1488MO Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT)

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma

735MO Updated safety and efficacy from SURPASS, the phase I trial of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in previously treated patients with unresectable or metastatic tumors

1677PD - A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy

A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma

1670O - ADP-A2M4 (MAGE-A4) in patients with synovial sarcoma

1687P - Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma

Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma

ADP-A2M4 (MAGE-A4) in patients with synovial sarcoma

Multi-institutional Analysis of Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases: High Rates of Local Control with Favorable Toxicity

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Suchergebnisse filtern